Bain and Cinven seek full control over Stada
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Stada Arzneimittel’s controlling shareholders, Bain Capital and Cinven, have made an improved offer to minority shareholders as they seek to take full control of the German generics and OTC specialist and delist the company.